Financial Performance - Revenues for 2024 increased by 4.1% to $558,514,000 compared to $536,766,000 in 2023[167] - Net income rose by 9% to $109,002,000 in 2024, up from $100,339,000 in 2023, with diluted earnings per share increasing to $2.11 from $1.94[162] - Total operating income increased to $119,557,000 in 2024, up 7.4% from $111,322,000 in 2023[176] - Other income increased by 13.2% to $27,813,000, primarily due to a $2,851,000 rise in interest income from cash and cash equivalents[178] - EBITDA for 2024 was $147,058,000, representing 28.4% of revenues before reimbursements, up from 27.7% in 2023[191] - Effective tax rate decreased to 26.0% in 2024 from 26.2% in 2023, with an adjusted rate of 27.9% excluding excess tax benefits[179] Segment Performance - Engineering and Other Scientific segment revenues increased by 5.1% to $469,544,000, accounting for 84.1% of total revenues[167] - Environmental and Health segment revenues decreased by 1.0% to $88,970,000, representing 15.9% of total revenues[167] - Engineering and Other Scientific segment operating income rose by 7.1% to $164,883,000, driven by increased billing rates and billable hours[176] Expenses - Compensation and related expenses increased by 3.2% to $330,011,000, constituting 59.1% of total revenues[170] - Other operating expenses rose by 11.2% to $46,196,000, making up 8.3% of total revenues[172] - General and administrative expenses decreased by 7.0% to $22,726,000, representing 4.1% of total revenues[174] Utilization and Operations - Utilization rate improved to 73% in 2024 from 69% in 2023, driven by better alignment of resources with demand[166] - Billable hours remained constant at 1,495,000 for both 2024 and 2023, with a slight increase in utilization[166] - Utilization rate improved to 73% in 2024, up from 69% in 2023, reflecting increased demand for services[192] Cash Flow and Investments - Net cash provided by operating activities was $144,537,000 in 2024, compared to $127,352,000 in 2023[181] - Cash and cash equivalents increased to $258,901,000 as of January 3, 2025, from $187,150,000 at December 29, 2023[181] - The company plans to continue investing in capital expenditures and may use cash reserves for stock repurchases and strategic acquisitions[186] Strategic Focus - The company continues to focus on expanding client relationships and enhancing its capabilities in response to increasing demand for multidisciplinary services[161] Foreign Currency Exposure - The company has net assets of approximately $24.2 million in British Pounds, indicating exposure to foreign currency risk[196]

Exponent, Inc. (NASDAQ:EXPO) Q4 2024 Earnings Conference Call February 6, 2024 4:30 PM ET Company Participants Joni Konstantelos - MD, Riveron Consulting Catherine Corrigan - President and CEO Rich Schlenker - EVP and CFO Conference Call Participants Andrew Nicholas - William Blair Tobey Sommer - Truist Josh Chan - UBS Operator Good day, and welcome to the Exponent, Inc. Q4 2024 Earnings Conference Call. Please note this event is being recorded. I would now like to turn the conference over to Joni Konstante ...

Exponent (EXPO) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.48 per share when it actually produced earnings of $0.50, delivering a surprise of 4.17%.Over the last ...

Exponent (EXPO) Q4 2024 Earnings Call February 06, 2025 04:30 PM ET Company Participants Joni Konstantelos - Investor RelationsCatherine Corrigan - President and Chief Executive OfficerRich Schlenker - Executive Vice President and Chief Financial Officer.Tobey Sommer - Managing Director Conference Call Participants Andrew Nicholas - Equity Research AnalystJoshua Chan - Director, Equity Research Analyst Operator Please note this event is being recorded. I would now like to turn the conference over to Joni Ko ...

EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2024 Financial Results MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter results exceeded expectations, capping off a solid year that demonstrated the resilience of the business. With a laser focus on aligning resources with demand, we grew net revenues in the mid-single digits for the year and a ...

MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter results exceeded expectations, capping off a solid year that demonstrated the resilience of the business. With a laser focus on aligning resources with demand, we grew net revenues in the mid-single digits for the year and at the same time delivered significantly improved utilization and EBITDA1 margin. We ...

MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The quarterly cash dividend of $0.30 per share of common stock is to be paid on March 21, 2025 to all common stockholders of record as of March 7, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of ...

MENLO PARK, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Fourth Quarter and fiscal year 2024 financial results for the period ended January 3, 2025 following the close of the market on Thursday, February 6, 2025. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to___________ Commission File Number 0-18655 EXPONENT, INC. (Exact name of registrant as specified in its charter) DELAWARE 77-0218904 (State ...

Economic strength, encouraging service activities, increased adoption, and the success of the work-from-home trend enable Zacks Consulting Services industry players to support the demand environment. Driven by these positives, investors interested in the industry would do well to keep stocks like Gartner, Inc. (IT) , Stantec Inc. (STN) and Exponent, Inc. (EXPO) in their portfolio. About the Industry Companies grouped under the Consulting Services category offer professional advice in management, IT, human r ...